MMP9 and colorectal carcinoma: However, MMP-9 proteolytic activity in the serum of patients with adenomas remained systematically in the same range as in healthy subjects, suggesting the interest of this biomarker in differentiating patients with precancerous lesions (adenomas) from those with CRC [384].